A Day 14 Endpoint for Acute GVHD Clinical Trials

Spyrou, N., Akahoshi, Y., Kowalyk, S., Morales, G., Beheshti, R., Aguayo-Hiraldo, P., Al Malki, M. M., Ayuk, F., Bader, P., Baez, J., Capellini, A., Choe, H., DeFilipp, Z., Eder, M., Eng, G., Etra, A., Gleich, S., Grupp, S. A., Hexner, E., … Ferrara, J. L. M. (2024). A Day 14 Endpoint for Acute GVHD Clinical Trials. Transplantation and Cellular Therapy, 30(4), 421–432. https://doi.org/10.1016/j.jtct.2024.01.079
Authors:
Nikolaos Spyrou
Yu Akahoshi
Steven Kowalyk
George Morales
Rahnuma Beheshti
Paibel Aguayo-Hiraldo
Monzr M Al Malki
Francis Ayuk
Peter Bader
Janna Baez
Alexandra Capellini
Hannah Choe
Zachariah DeFilipp
Matthias Eder
Gilbert Eng
Aaron Etra
Sigrun Gleich
Stephan A Grupp
Elizabeth Hexner
Matthias Hoepting
William J Hogan
Stelios Kasikis
Nikolaos Katsivelos
Alina Khan
Carrie L Kitko
Sabrina Kraus
Deukwoo Kwon
Pietro Merli
Joseph Portelli
Muna Qayed
Ran Reshef
Tal Schechter
Ingrid Vasova
Matthias Wölfl
Kitsada Wudhikarn
Rachel Young
Ernst Holler
Yi-Bin Chen
Ryotaro Nakamura
John E Levine
James L M Ferrara
Affiliated Authors:
Ran Reshef
Author Keywords:
acute gvhd
biomarkers
endpoints
treatment response
immunosuppression
nonrelapse mortality
competing risks
surrogate
composite
machine learning
competing risk
time-dependent auc
decision curve analysis
classification and regres-sion tree
classification and regression tree
Publication Type:
Article
Unique ID:
10.1016/j.jtct.2024.01.079
PMID:
Publication Date:
Data Source:
PubMed

Record Created: